![This stock is seen as Nvidia's 'little brother'](https://i-invdn-com.investing.com/news/LYNXMPEB1A16P_S.jpg)
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1049 | 1011 | 1051 | 1039 | 1297 | 2276 |
Fund Return | 4.87% | 1.15% | 5.06% | 1.29% | 5.33% | 8.57% |
Place in category | 642 | 277 | 565 | 411 | 352 | 161 |
% in Category | 62 | 29 | 64 | 64 | 81 | 60 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
S-Asuntorahasto | 463.26M | 5.61 | -3.44 | - | ||
FIM Emerging markets ESG | 376.23M | -1.19 | -2.57 | 4.27 | ||
S SaastOrahasto Kohtuullinen | 286.82M | 5.82 | 3.59 | 5.88 | ||
S-Saastorahasto Rohkea | 251.52M | 8.56 | 6.47 | 8.40 | ||
FIM USA | 234.4M | 15.22 | 12.38 | 12.82 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Danske Invest MediLife T | 577.52K | 8.06 | 10.80 | 11.54 | ||
Danske Invest MediLife K | 93.93M | 8.06 | 10.79 | 11.54 | ||
Seligson Global Top 25 Pharmac B | 268.79M | 6.08 | 11.04 | 8.93 | ||
Seligson Co Global Top 25 Pharma A | 268.79M | 6.08 | 11.03 | 8.91 | ||
LahiTapiola Hyvinvointi B | 140.47M | 4.87 | 1.30 | 8.57 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 6.45 | 902.12 | -0.28% | |
Novo Nordisk B | DK0062498333 | 6.37 | 1,007.0 | -2.04% | |
Vertex | US92532F1003 | 3.58 | 473.27 | -0.12% | |
Amgen | US0311621009 | 3.41 | 313.15 | -1.93% | |
AstraZeneca | GB0009895292 | 3.25 | 12,556.0 | +0.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review